Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Prognostic factors and therapeutic outcomes in neurolymphomatosis: A 22-year cohort study from Mayo Clinic

Ayo Falade, Abiola Bolarinwa, Oluwatayo Adeoye, Muhammad Yousuf, Allison Rosenthal, Mazie Tsang, Madiha Iqbal, Daniel Lachance, Rebecca King, Yucai Wang, Micallef Ivana, Robert Spinner, Thomas Habermann, Grzegorz Nowakowski, Arushi Khurana, Patrick Johnston

Blood (2025) 146 (Supplement 1): 6306.

https://doi.org/10.1182/blood-2025-6306

Published: 2025

Journal Articles

Intratumoral B cell diversity in follicular lymphoma revealed by single-cell paired transcriptome and BCR sequencing

Miranda Siminski, Janek Walker, Joseph Novak, Abigail Dropik, Zilin Xianyu, Zhi-Zhang Yang, Matthew Maurer, Thomas Habermann, Rebecca King, Thomas Witzig, Stephen Ansell, James Cerhan, Patrizia Mondello, Anne Novak

Blood (2025) 146 (Supplement 1): 5342.

https://doi.org/10.1182/blood-2025-5342

Published: 2025

Journal Articles

Bioflipi scores define distinct immune profiles in follicular lymphoma

Jordan Krull, Qin Ma, Emmanuel Contreras Guzman, Rebecca King, Andrew Feldman, Surendra Dasari, Diwakar Suresh, Jose Villasboas Bisneto, Matthew Maurer, Brian Link, Eric Hsi, Grzegorz Nowakowski, Thomas Habermann, Anne Novak, Melissa Larson, James Cerhan, Stephen Ansell, Patrizia Mondello

Blood (2025) 146 (Supplement 1): 5328.

https://doi.org/10.1182/blood-2025-5328

Published: 2025

Journal Articles

NOTCH pathway activation is mediated by DTX1 loss of function mutations in DLBCL

Blood (2025) 146 (Supplement 1): 1771.

https://doi.org/10.1182/blood-2025-1771

Published: 2025

Journal Articles

Prognostic significance of cell-of-origin, gene expression profiles, and frontline therapy in predicting secondary CNS lymphoma in newly diagnosed diffuse large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 473.

https://doi.org/10.1182/blood-2025-473

Published: 2025

Journal Articles

Lymphovision: A lymphoma-specialized foundation model for histology-based lymphoma classification and subtyping

Blood (2025) 146 (Supplement 1): 117.

https://doi.org/10.1182/blood-2025-117

Published: 2025

Journal Articles

Anatomical localization-based analysis of de novo secondary cns lymphoma

Izel Okcu, Zhuo Li, Launia White, Yucai Wang, Patrick Johnston, Allison Rosenthal, Arushi Khurana, Urshila Durani, Jonas Paludo, Rebecca King, Thomas Witzig, Thomas Habermann, Grzegorz Nowakowski, Han Tun

Blood (2025) 146 (Supplement 1): 3675.

https://doi.org/10.1182/blood-2025-3675

Published: 2025

Journal Articles

Efficacy of brentuximab vedotin combination treatment in patients with relapsed or refractory diffuse large B-cell lymphoma with CD30 <1% expression

Grzegorz Nowakowski, Rebecca King, Daniel Kearney, Nancy Bartlett, Jeong-A Kim, Isabelle Fleury, Luigina Mollica, Craig Portell, Christopher Yasenchak, Keenan Fenton, Christopher Hale, Diana Hubbard, Hailing Lu, Monica Patterson, Michelle Fanale, Evelyn Rustia, Uwe Hahn

Blood (2025) 146 (Supplement 1): 1905.

https://doi.org/10.1182/blood-2025-1905

Published: 2025

Journal Articles

Performance of molecular classifiers relative to the international prognostic index (IPI) for overall and event-free survival in diffuse large B-cell lymphoma (DLBCL)

Blood (2025) 146 (Supplement 1): 5301.

https://doi.org/10.1182/blood-2025-5301

Published: 2025

Journal Articles

Genetic evolution of Waldenström macroglobulinemia across disease stages

Blood (2025) 146 (Supplement 1): 3540.

https://doi.org/10.1182/blood-2025-3540

Published: 2025

Journal Articles

Pirtobrutinib versus usual care for patients with richter transformation of chronic lymphocytic leukemia: Inverse probability of treatment weighting-based analysis of BRUIN trial and mayo observational cohort

Yucai Wang, Kari Rabe, Paul Hampel, Lindsey Roeker, Jihao Zhou, Suheil Albert Atallah-Yunes, Susan Schwager, Min Shi, Curtis Hanson, Rebecca King, Cinthya Mendoza Zepeda, Saad Kenderian, Eli Muchtar, Neil Kay, Amber Koehler, Amy Behnken, Catherine Coddington, Susan Slager, Sameer Parikh

Blood (2025) 146 (Supplement 1): 5673.

https://doi.org/10.1182/blood-2025-5673

Published: 2025

Journal Articles

Molecular Classification of Relapsed DLBCL Reveals Novel Biologic Subgroups

Blood (2023) 142 (Supplement 1): 2770.

https://doi.org/10.1182/blood-2023-180949

Published: 2023

Journal Articles

Lymphoid Malignancy Risk with Rare Inherited Variants in Known Cancer Predisposition Genes

Blood (2023) 142 (Supplement 1): 2990.

https://doi.org/10.1182/blood-2023-182266

Published: 2023

Journal Articles

Tumor Mutational Burden As a Prognostic Factor in Diffuse Large B-Cell Lymphoma

Rosalie Griffin, Kerstin Wenzl, Vivekananda Sarangi, Lisa M. Rimsza, Rebecca King, Andrew L. Feldman, Matthew J. Maurer, Grzegorz S. Nowakowski, Brian K. Link, Thomas M. Habermann, Nicholas Stong, C. Chris Huang, Anita K. Gandhi, Susan L. Slager, Anne J. Novak, James R. Cerhan

Blood (2023) 142 (Supplement 1): 1633.

https://doi.org/10.1182/blood-2023-182291

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Prognostic factors and therapeutic outcomes in neurolymphomatosis: A 22-year cohort study from Mayo Clinic

Intratumoral B cell diversity in follicular lymphoma revealed by single-cell paired transcriptome and BCR sequencing

Bioflipi scores define distinct immune profiles in follicular lymphoma

NOTCH pathway activation is mediated by DTX1 loss of function mutations in DLBCL

Prognostic significance of cell-of-origin, gene expression profiles, and frontline therapy in predicting secondary CNS lymphoma in newly diagnosed diffuse large B-cell lymphoma

Lymphovision: A lymphoma-specialized foundation model for histology-based lymphoma classification and subtyping

Anatomical localization-based analysis of de novo secondary cns lymphoma

Efficacy of brentuximab vedotin combination treatment in patients with relapsed or refractory diffuse large B-cell lymphoma with CD30 <1% expression

Performance of molecular classifiers relative to the international prognostic index (IPI) for overall and event-free survival in diffuse large B-cell lymphoma (DLBCL)

Genetic evolution of Waldenström macroglobulinemia across disease stages

Pirtobrutinib versus usual care for patients with richter transformation of chronic lymphocytic leukemia: Inverse probability of treatment weighting-based analysis of BRUIN trial and mayo observational cohort

Molecular Classification of Relapsed DLBCL Reveals Novel Biologic Subgroups

Lymphoid Malignancy Risk with Rare Inherited Variants in Known Cancer Predisposition Genes

Tumor Mutational Burden As a Prognostic Factor in Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only